This is the authors' abstract. We don't add key points for this paper.
Inhalable RNA Immunotherapy In article number 2400307, Bowen Li and co-workers develop a tumor-tailored lipid nanoparticle system to deliver IL-12 circular RNA for enhanced lung cancer immunotherapy. Inhalation of these engineered nanoparticles can effectively induce immune activation, increase CD8+ T cell infiltration into tumor tissues, and lead to lung tumor regression, offering a promising strategy to improve treatment outcomes of lung cancer.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: